NorthShore and Ambry announce launch of new test to assess prostate cancer risk
NorthShore University HealthSystem's Center for Personalized Medicine and Ambry Genetics Corporation, announced today the launch of AmbryScore for prostate cancer risk.
More... |
All times are GMT -7. The time now is 09:01 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021